Tigecycline: A Critical Update

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of chemotherapy

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/joc.2008.20.4.411PMID 18676218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tigecycline

  2012cited by this paper
• Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.

  2008cited by this paper
• High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

  2007cited by this paper
• Early Experience with Tigecycline for Ventilator‐Associated Pneumonia and Bacteremia Caused by Multidrug‐Resistant Acinetobacter baumannii

  2007cited by this paper
• Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections

  2007cited by this paper
• Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm

  2007cited by this paper
• Community-Acquired Methicillin-Resistant Staphylococcus Aureus Skin Infections

  2007cited by this paper
• Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for Tigecycline

  2007cited by this paper
• Evidence for low risk of Clostridium difficile infection associated with tigecycline.

  2007cited by this paper
• Tigecycline: Its potential for treatment of brucellosis

  2007cited by this paper
• Clonal Diversity and Resistance Mechanisms in Tetracycline-Nonsusceptible Streptococcus pneumoniae Isolates in Poland

  2007cited by this paper
• Tigecycline: A Novel Broad-Spectrum Antimicrobial

  2007cited by this paper
• Enteral Vancomycin Controls Methicillin-resistant Staphylococcus Aureus Endemicity in an Intensive Care Burn Unit: A 9-Year Prospective Study

  2007cited by this paper
• In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.

  2007cited by this paper
• Enterococci and streptococci.

  2007cited by this paper
• Predictors of Efficacy and Health Resource Utilization in Treatment of Complicated Intra-abdominal Infections: Evidence for Pooled Clinical Studies Comparing Tigecycline with Imipenem–Cilastatin

  2007cited by this paper
• Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

  2007cited by this paper
• Rapid Development of Acinetobacter baumannii Resistance to Tigecycline

  2007cited by this paper
• Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobial.

  2007cited by this paper
• Functional, Biophysical, and Structural Bases for Antibacterial Activity of Tigecycline

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

  2006cited by this paper
• Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.

  2006cited by this paper
• Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

  2006cited by this paper
• In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals

  2006cited by this paper
• Tigecycline: a critical analysis.

  2006cited by this paper
• Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial

  2006cited by this paper
• Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations

  2005cited by this paper
• Tigecycline is modified by the flavin-dependent monooxygenase TetX.

  2005cited by this paper
• Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects

  2005cited by this paper
• Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.

  2005cited by this paper
• The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

  2005cited by this paper
• Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

  2005cited by this paper
• Methicillin-resistant Staphylococcus aureus disease in three communities.

  2005cited by this paper
• The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.

  2005cited by this paper
• Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.

  2005cited by this paper
• Tigecycline.

  2005cited by this paper
• Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline

  2005cited by this paper
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Tigecycline

  2005cited by this paper
• Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients.

  2004cited by this paper
• The glycylcyclines: a comparative review with the tetracyclines.

  2004cited by this paper
• Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.

  2004cited by this paper
• Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

  2003cited by this paper
• Activities of Tigecycline (GAR-936) against Legionella pneumophila In Vitro and in Guinea Pigs with L. pneumophila Pneumonia

  2003cited by this paper
• In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria

  2000cited by this paper

• The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation

  2025cites this paper
• Genomic Insights into Colistin and Tigecycline Resistance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Harboring blaKPC Genes in Ecuador

  2025cites this paper
• Tigecycline Containing Polymethylmethacrylate Cement Against MRSA, VRE, and ESBL—In Vitro Mechanical and Microbiological Investigations

  2024cites this paper
• Modeling of the Adsorption of Tigecycline from Water on CoFe2O4-Graphene Nanocomposites.

  2024cites this paper
• Sequence-structure-function characterization of the emerging tetracycline destructase family of antibiotic resistance enzymes

  2024cites this paper
• Molecular interaction of a putative inhibitor with bacterial SHV, an enzyme associated with antibiotic resistance

  2023cites this paper
• Disruption of methicillin-resistant Staphylococcus aureus protein synthesis by tannins.

  2017cites this paper
• Transcriptome analysis of methicillin-resistant Staphylococcus aureus in response to stigmasterol and lupeol.

  2017cites this paper
• Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.

  2017cites this paper
• 76 – Peritonitis and Intraperitoneal Abscesses

  2015cites this paper
• A Region-specific Treatment Strategy To Address The Problem Of Drug Resistance By NDM-1-producing Pathogens

  2013cites this paper
• A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus

  2013cites this paper
• Clinical Issues of Resistance: Problematic Microbes: Enterobacteriaceae

  2012cites this paper
• Transcriptome Analysis of Responses to Rhodomyrtone in Methicillin-Resistant Staphylococcus aureus

  2012cites this paper
• New Delhi Metallo-β-Lactamase (NDM-1): An Updates

  2011cites this paper
• Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.

  2011cites this paper
• Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase

  2011cites this paper
• Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated β-Lactam Resistance by Delocalizing PBP2

  2010cites this paper
• Factors Associated with Adherence to Guidelines for the Use of Tigecycline in a Tertiary Care Hospital

  2010cites this paper
• Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.

  2010cites this paper
• Unexpected Tigecycline Resistance Among Acinetobacter baumannii Isolates: High Minor Error Rate by Etest

  2009cites this paper
• Antimicrobial resistance in Bacteroides spp.: occurrence and dissemination.

  2009cites this paper
• Doripenem Versus Bacteria: An Emerging Battleground

  2009cites this paper
• Studies on multi_drug resistance in urinary tract infection patients

  2009cites this paper
• Severe Community-Acquired Pneumonia in Critical Care

  2009cites this paper
• Successful Treatment of Stenotrophomonas maltophilia Soft Tissue Infection with Tigecycline: a Case Report

  2009cites this paper